MRK
NYSE · Pharmaceuticals
Merck & Co. Inc.
$146.94
-3.42 (-2.27%)
EPS Surprise History
Earnings Summary
Beats (Last 7)
7/7
Avg Surprise
+16.2%
Consecutive Beats
7 quarters
Latest EPS
$2.49
YoY EPS Growth
-7.1%
History
7 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | Q4 FY2026 | $2.12 | — | — | — | — |
| Sep 30, 2026 | Q3 FY2026 | $2.10 | $2.49 | +$0.39 | +18.5% | Beat |
| Aug 4, 2026 | Q3 FY2026 | $-0.28 | — | — | — | — |
| Jun 30, 2026 | Q2 FY2026 | $-0.27 | $-0.13 | +$0.14 | +52.3% | Beat |
| Apr 30, 2026 | Q2 FY2026 | $-1.35 | — | — | — | — |
| Mar 31, 2026 | Q1 FY2026 | $-1.52 | $-1.28 | +$0.24 | +16.0% | Beat |
| Dec 31, 2025 | Q4 FY2025 | $2.03 | $2.09 | +$0.06 | +3.0% | Beat |
| Sep 30, 2025 | Q3 FY2025 | $2.37 | $2.68 | +$0.31 | +13.1% | Beat |
| Jun 30, 2025 | Q2 FY2025 | $2.03 | $2.19 | +$0.16 | +7.7% | Beat |
| Mar 31, 2025 | Q1 FY2025 | $2.16 | $2.22 | +$0.06 | +2.9% | Beat |